BDBM50299101 6-(5-Methyl-1,3,4-oxadiazol-2-yl)-3-[4-(methylsulfinyl)phenyl]imidazo[1,2-a]pyridine::CHEMBL576336
SMILES: Cc1ccc(o1)-c1ccc2ncc(-c3ccc(cc3)S(C)=O)n2c1
InChI Key: InChIKey=UZRYFKGRTKHBGX-UHFFFAOYSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Glycogen synthase kinase-3 beta (Homo sapiens (Human)) | BDBM50299101 (6-(5-Methyl-1,3,4-oxadiazol-2-yl)-3-[4-(methylsulf...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem | Article PubMed | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company, Ltd. Curated by ChEMBL | Assay Description Inhibition of human recombinant GSK3-beta | J Med Chem 52: 6270-86 (2009) Article DOI: 10.1021/jm900647e BindingDB Entry DOI: 10.7270/Q2CZ377V | |||||||||||
More data for this Ligand-Target Pair |